Centers for Disease Control and Prevention

Sugar Editorial Picks

Doctors List Who Should Die in a Pandemic

May 06, 2008 - If a global and deadly pandemic hits, doctors will have to chose who to save, and thus, who to let die. Prominent doctors have now put out a definitive list of who is in and who is out. They made the list at the behest of prominent universities and military and US governmental agencies, including the Department of Homeland Security, the Centers for Disease Control and Prevention and the Department of Health and Human Services. - 64 Comments

Other Search Results

US STD Rate Highest of Developed Countries — and Rising!

Nov 16, 2009 - Let's talk about sex . . . - 6 Comments

Crohn's disease

Oct 08, 2008 - In This Report

Highlights
Introduction
Causes
Symptoms
Complications
Risk Factors
Diagnosis
Dietary Factors
Symptom Management
Medications
Surgery
Resources
References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Biologic Drugs

In February 2007, the FDA approved adalimumab (Humira) for treatment of adult patients with moderate-to-severe Crohn’s disease. Adalimumab and infliximab (Remicade) are now the two biologic drugs approved for Crohn’s disease. Infliximab is approved for treating both adults and children.
As of August 2007, the FDA was considering approving natalizumab (Tysabri) for moderate-to-severe Crohn’s disease in patients who have not responded to, or cannot tolerate, other therapies. - 0 Comments
Read More ›

Clash of Cultures Puts Latina Teens in Danger of Suicide

Oct 20, 2009 - According to the Centers For Disease Control and Prevention, one out of seven Latina teenagers attempts suicide. Psychologist Dr. Luis Zayas of Washington University, who has spent the last 25 years studying Latina teens, believes that this rate is so high because of the teens' troubled relationships with their mothers. - 16 Comments

Coronary artery disease

Oct 08, 2008 - In This Report

Highlights
Introduction
Prognosis
Risk Factors
Diagnosis
Managing Heart Disease
Anti-Clotting Medications...
Other Medications
Surgery
Coronary Artery Bypass Graf...
Angioplasty and Stents
Other Treatments
Resources
References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Angioplasty Versus Drugs Angioplasty works no better than drug therapy (high blood pressure, cholesterol, anti-platelet, and other medication) in preventing heart attack and stroke in patients with stable coronary artery disease (CAD), according to an important New England Journal of Medicine study. Experts still recommend angioplasty for patients with unstable or severe CAD. Stents

Stents coated with drugs may have a slightly higher risk of causing blood clots than bare metal stents, according to FDA meetings held in late 2006. - 0 Comments
Read More ›

Lyme disease and related tick-borne infections

Oct 08, 2008 - In This Report

Highlights
Introduction
Symptoms
Risk Factors
Complications
Diseases with Similar Sympt...
Diagnosis
Treatment
Prevention
Human Granulocytic Anaplasm...
Babesiosis
Resources
References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Lyme Disease Rates Double in Past 15 Years The annual number of people newly infected with Lyme disease has doubled from around 10,000 cases per year in the early 1990s to about 20,000 cases per year now. Improved diagnosis and reporting probably contribute to this increase. In the United States, Massachusetts, New Jersey, and Pennsylvania have reported the highest number of Lyme disease cases in recent years. - 0 Comments

Diabetes - type 1

Oct 08, 2008 - In This Report

Highlights
Introduction
Causes
Risk Factors
Symptoms
Life-Threatening Complicati...
Diagnosis
Dietary Goals and Exercise...
Treatment
Monitoring Tests
Long-Term Complications
Transplantation Procedures...
Prevention
Resources
References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights New Continuous Glucose Meter System In 2007, the FDA approved the STS-7 System, which monitors glucose levels every 5 minutes during a 7-day period. The STS-7 System, like other continuous glucose meter systems, is designed to be used in combination with traditional fingerstick tests and meters. It does not replace them. - 3 Comments

Diabetes - type 2

Oct 08, 2008 - In This Report

Highlights
Introduction
Causes
Risk Factors
Symptoms
Screening Tests
Treatment
Lifestyle Changes
Medications
Long-Term Complications
Emergency Complications
Resources
References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Drug Approvals

Sitagliptin (Januvia), the first in a new class of diabetes drugs called DPP-4 inhibitors, was approved in 2006.
Janumet, a 2-in-1 pill that contains both sitagliptin and metformin, was approved in 2007.
These drugs are taken by mouth and may be more convenient for patients than exenatide (Byetta), a similar drug. DPP-4 inhibitors do not cause weight gain and may pose a lower risk for hypoglycemia than some other diabetes drugs.

Drug Safety Alert Rosiglitazone (Avandia) may significantly increase the risk for heart attack, indicates a review published in the Journal of the American Medical Association. In 2007, a panel of experts from the Food and Drug Administration (FDA) agreed the drug increases the risk of heart attacks -- but concluded it should remain on the market. - 4 Comments

Cirrhosis

Oct 08, 2008 - In This Report

Highlights
Introduction
Causes
Risk Factors
Symptoms
Complications
Diagnosis
Treatment
Lifestyle Changes
Abdominal Infections
Encephalopathy
Ascites
Bleeding Episodes
Resources
References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Drug Approval In 2007, the Food and Drug Administration approved HepaGram B, an injectable immune globulin that can help prevent recurrence of hepatitis B following liver transplantation. Primary Biliary Cirrhosis Primary biliary cirrhosis is an autoimmune liver disease that increases the risk for liver cancer. According to a 2007 study, specific risk factors may help predict which patients with primary biliary cirrhosis are at particularly high risk of developing liver cancer. - 0 Comments

Heart attack and acute coronary syndrome

Oct 08, 2008 - In This Report

Highlights
Introduction
Symptoms
Prognosis
Risk Factors
Diagnosis
Treatment
Medications
Surgery
Rehabilitation
Resources
References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Drug Approval In 2006, the FDA approved the use of clopidogrel (Plavix) for patients who have had a STEMI heart attack and who will not be having angioplasty. A STEMI is a very severe type of heart attack caused by sudden and total artery blockage. Angioplasty and Stents Surgery with angioplasty and stents that is performed more than 3 days after a heart attack offers no advantage over standard drug therapy for clinically stable patients, indicates an important 2006 New England Journal of Medicine study. - 3 Comments